News

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.
Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...
By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -Danish drugmaker Novo Nordisk introduced its weight-loss drug ...
Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...
Danish drug maker Novo Nordisk introduced its weight-loss drug Wegovy in SA on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly’s Mounjaro which ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
Dow Jones Top Company Headlines at 5 AM ET: Novo Nordisk shares are rising. The FDA approves another use for Wegovy. | How ... Novo Nordisk shares are rising. The FDA approves another use for Wegovy.
However, the late-stage study results fell short of Novo Nordisk ’s injectable Wegovy, which delivered 14.9 per cent weight loss over 68 weeks in a 2021 trial.
Novo Nordisk A/S (NYSE:NVO), the Danish pharmaceutical giant renowned for its weight-loss drug Wegovy and diabetes treatment Ozempic, experienced a significant downturn on Tuesday following the ...
The period closed out with Novo Nordisk’s Wegovy knocking Skyrizi down a peg in June. Amid the shake-up, the 10 biggest brands spent $219.4 million getting their promos on TV screens.